National Nov 12, 2021
Takeda applies for approval of Moderna's booster shots in Japan
A government subcommittee of health experts will discuss the use of the vaccine as a booster shot in late December at the earliest.
Takeda applies for approval of Moderna's booster shots in Japan
A government subcommittee of health experts will discuss the use of the vaccine as a booster shot in late December at the earliest.
Regeneron antibody prevents COVID-19 infections for eight months
The company has asked the U.S. Food and Drug Administration to expand the authorization so the drug can be used to prevent infections.
Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%
The drugmaker claims "overwhelming efficacy” and plans to submit their findings for emergency authorization as soon as possible.
U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people
If the FDA signs off on Moderna's booster, the U.S. Centers for Disease Control and Prevention will make specific recommendations on who should get the shots.
AstraZeneca drug effective at treating mild COVID-19 symptoms in trial
The antibody cocktail from AstraZeneca may offer a simple way of treating patients before they ever visit the hospital.
Moderna, racing for profits, keeps COVID-19 vaccine out of reach of poor
Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, a data-tracking firm has said.
Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11
The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.
A Chilean tree holds hope for new vaccines — if supplies last
Quillay trees, technically known as Quillaja saponaria, are rare evergreens native to Chile that have long been used by the indigenous Mapuche people to make soap and medicine.
Pfizer COVID-19 shot safely bolsters antibodies in younger kids
In a trial, two shots of a 10 microgram dose — one-third of the adult shot — produced antibody levels comparable to those seen in a trial of 16- to 25-year-olds who got the adult dose.
Third man in Japan died after receiving recalled Moderna vaccine
The 49-year-old man, who was allergic to buckwheat, received his second shot on Aug. 11 and his death was confirmed the following day.
Japan finds another Moderna vial suspected to contain foreign substance
Kanagawa Prefecture said it had put the suspected lot of the firm's COVID-19 vaccine on hold after about 3,790 people had already received shots from the same lot.
Foreign substances in Japan's Moderna shots: Here's what you need to know
Other possibly contaminated batches have been reported in recent days, but experts say health risks are low.